MUZI, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 8.765
EU - Europa 1.939
AS - Asia 827
SA - Sud America 95
AF - Africa 10
OC - Oceania 4
Totale 11.640
Nazione #
US - Stati Uniti d'America 8.746
IT - Italia 1.039
SG - Singapore 358
CN - Cina 208
DE - Germania 182
FR - Francia 134
UA - Ucraina 121
RU - Federazione Russa 110
BR - Brasile 77
VN - Vietnam 76
NL - Olanda 64
IE - Irlanda 62
HK - Hong Kong 60
SE - Svezia 53
FI - Finlandia 42
GB - Regno Unito 41
PL - Polonia 40
JP - Giappone 25
KR - Corea 25
BD - Bangladesh 21
CZ - Repubblica Ceca 21
IN - India 12
CA - Canada 9
MX - Messico 9
AR - Argentina 7
ES - Italia 7
ID - Indonesia 6
TR - Turchia 6
UZ - Uzbekistan 5
AU - Australia 4
CH - Svizzera 4
PH - Filippine 4
AT - Austria 3
CO - Colombia 3
KE - Kenya 3
LT - Lituania 3
MY - Malesia 3
PK - Pakistan 3
ZA - Sudafrica 3
AL - Albania 2
BG - Bulgaria 2
HR - Croazia 2
IL - Israele 2
IQ - Iraq 2
KZ - Kazakistan 2
MA - Marocco 2
TW - Taiwan 2
UY - Uruguay 2
VE - Venezuela 2
BE - Belgio 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
EC - Ecuador 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
IR - Iran 1
KG - Kirghizistan 1
LB - Libano 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PT - Portogallo 1
RO - Romania 1
SR - Suriname 1
SY - Repubblica araba siriana 1
ZW - Zimbabwe 1
Totale 11.640
Città #
Woodbridge 2.643
Houston 2.106
Wilmington 1.937
Ann Arbor 244
Singapore 228
Chandler 226
Fairfield 219
Ashburn 162
Rome 106
Jacksonville 104
Seattle 83
San Jose 82
New York 76
Beijing 74
Milan 73
Cambridge 65
Dublin 61
Hong Kong 58
Medford 51
Dallas 42
The Dalles 34
Santa Clara 33
Council Bluffs 31
Los Angeles 31
Kraków 30
Dearborn 28
Ho Chi Minh City 24
Lawrence 24
Prague 21
Naples 20
Tokyo 19
Helsinki 18
Mülheim 18
Buffalo 15
Catania 14
Zhengzhou 14
Florence 13
Hanoi 13
Palo Alto 13
Turin 13
Falls Church 12
Guangzhou 12
Shanghai 12
Boardman 11
Menlo Park 11
Moscow 10
Columbus 9
Pisa 9
San Diego 9
Verona 9
Bologna 8
Civitavecchia 8
Hefei 8
São Paulo 8
Bari 7
London 7
Pioppi 7
University Park 7
Brescia 6
Mountain View 6
Napoli 6
Pavia 6
Da Nang 5
Lauterbourg 5
Orem 5
Phoenix 5
Reggio Emilia 5
San Mateo 5
Toronto 5
Atlanta 4
Calusco d'Adda 4
Chicago 4
Jakarta 4
Nanjing 4
Novara 4
Nuremberg 4
Padova 4
Palermo 4
Redwood City 4
Saint Petersburg 4
Tashkent 4
Treviso 4
Altopascio 3
Brasília 3
Cagliari 3
Chennai 3
Curitiba 3
Dong Ket 3
Ercolano 3
Ferrara 3
Fidenza 3
Haiphong 3
Jinan 3
Kunming 3
Lecce 3
Manchester 3
Massa 3
Montreal 3
Pordenone 3
Pune 3
Totale 9.395
Nome #
Gli inibitori della poli (ADP-ribosio) polimerasi (PARP) per superare la chemioresistenza a metilanti e inibitori di topoisomerasi I 1.569
Common fragile sites in colon cancer cell lines: role of mismatch repair, RAD51 and poly(ADP-ribose) polymerase-1 533
Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells 492
Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide 481
Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity 480
A novel water-soluble nitrobenzoxadiazole is highly effective against vemurafenib-resistant human melanoma cells 477
The integrin antagonist cilengitide increases the antitumor activity of temozolomide against malignant melanoma 461
Poly(ADP-ribose) polymerase signaling of topoisomerase 1-dependent DNA damage in carcinoma cells 459
Oral administration of PARP inhibitor GPI 18180 increases the anti-tumor activity of temozolomide against intracranial melanoma in mice. 454
Novel Glutathione S-Transferase Inhibitor Enhances Temozolomide Efficacy Against Malignant Melanoma 52nd Annual Meeting of the Italian Cancer Society. Lost in translation: bridging the gap between cancer research and effective therapies 453
The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma 447
Role of PARP, NF-kB and telomerase in necrosis induced by selective methylation of N3-adenine. 439
Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide. 432
Pharmacological Inhibition of Poly(ADP-ribose) Polymerase (PARP) Activity in PARP-1 Silenced Tumour Cells Increases Chemosensitivity to Temozolomide and to a N3-Adenine Selective Methylating Agent. 427
Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis 426
Pharmacological inhibition of poly(ADP-ribose) polymerase activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells 422
Pharmacological inhibition of poly (ADP-ribose) polymerase (PARP) activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells and increases temozolomide sensitivity of PARP-1 silenced melanoma cells. 416
Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype. 413
Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-κB 411
Evidence of the crucial role of the linker domain on the catalytic activity of human topoisomerase I by experimental and simulative characterization of the Lys681Ala mutant 405
Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs. 401
Targeting angiogenesis with poly(ADP-ribose) polymerase inhibitors 393
Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma. 375
Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity to temozolomide. 17th International Symposium on poly(ADP-ribosyl)ation. 364
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 56
Totale 11.686
Categoria #
all - tutte 23.891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.891


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022296 9 29 25 13 5 32 6 8 45 36 6 82
2022/2023582 50 50 27 78 38 92 26 41 72 26 43 39
2023/2024449 43 22 38 44 30 87 36 25 18 22 32 52
2024/2025772 44 145 91 63 53 72 45 53 70 38 43 55
2025/20261.154 127 47 139 61 83 49 154 152 143 97 46 56
2026/20271 1 0 0 0 0 0 0 0 0 0 0 0
Totale 11.686